Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Sinil Pharm Co., Ltd. (012790)
Market Closed
11 Aug, 06:30
KRX SM
All
(1)
KR
(1)
KRX SM
Primary
₩
5,840.
00
+150
+2.6362%
₩
59.76B
Market Cap
-
P/E Ratio
760%
Div Yield
28,773
Volume
-
Eps
₩
5,690
Previous Close
Watching
Watch
Add Transaction
Day Range
5,610
5,890
Year Range
4,820
6,820
Want to track
012790
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Splits
Statistics
Historical Data
Sinil Pharm Co., Ltd. (012790) Statistics
Valuation metrics
Market Cap
59.76B
Enterprise value
21.72B
Trailing P/E (ttm)
7.94
Forward P/E
-
PEG ratio
-0.28
Price/Sales (ttm)
0.73
Price/Book (mrq)
0.39
Enterprise Value/Revenue
0.26
Enterprise Value/EBITDA
1.69
Overview
Shares outstanding
11.56M
Float
7.58M
Shares short
-
% Held by insiders
0.33%
% Held by institutions
0%
Average volume (10 days)
39.8K
Average volume (90 days)
33.76K
Price summary
52-Week low
4,820
52-Week high
6,820
Beta
0.49
50-Day moving average
5,985
200-Day moving average
6,048.85
Dividends and splits
Forward annual dividend rate
760
Forward annual dividend yield
0.147%
Trailing annual dividend rate
190
Trailing annual dividend yield
0.0368%
5-Year annual dividend yield
1.93%
Payout ratio
0.32
Dividend Date
5 Jan 2026
Ex-Dividend Date
29 Dec 2025
Last split factor
1:1
Last split Date
28 Dec 2022
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.08%
Operating margin
0.06%
Operational effectiveness
Return on assets
0.02%
Return on equity
0.05%
Income Statement
Revenue (ttm)
82.18B
Revenue per share (ttm)
6,969.44
Quarterly revenue growth (yoy)
0.08%
Gross profit (ttm)
35.2B
EBITDA
10.63B
Net income to common (ttm)
6.95B
Diluted EPS (ttm)
651
Quarterly earnings growth (yoy)
-0.29%
Balance Sheet
Total cash (mrq)
38.29B
Total cash per share (mrq)
3,312.72
Total debt (mrq)
248.64M
Total Debt/Equity (mrq)
0.16
Current ratio (mrq)
5.56%
Book value per share (mrq)
13,277.4
Cash Flow
Cash flow statement
9.45B
Levered free cash flow (LFCF)
460.27M